ZBHZimmer Biomet
$89.12-10% 1Y
$89.12
$79.5852 weeks$103.42
The financials
Zimmer Biomet by the numbers
Zimmer Biomet (ZBH) reported revenue of $2.18B in Q2 2026 (quarter ended Jun 30, 2026), up 4.8% from the same quarter a year earlier. That came with a gross margin of 71% and net income of $198M (9.1% of revenue). For the full year FY2025, revenue was $8.23B (+7.2% year on year) and net income $705M. Its largest product in Q2 2026 was Knees at $829M, 38% of the disclosed total, ahead of SET at 27%. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $2.18B | $2.08B | +4.8% |
| Gross profit | $1.54B | $1.49B | +3.8% |
| Operating income | $326M | $300M | +8.7% |
| Net income | $198M | $153M | +30% |
| Diluted EPS | $1.03 | $0.77 | +34% |
| Product | Revenue | Share |
|---|---|---|
| Knees | $829M | 38% |
| SET | $586M | 27% |
| Hips | $563M | 26% |
| Technology And Data Bone Cement And Surgical | $199M | 9.2% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $2.18B (+4.3%)
Technology And Data Bone Cement And Surgical grew +21% year on yearKnees +0.35% year on year
Segment Latestquarter on quarteryear on year
- Knees$828.9M$828.9Mquarter on quarter +0.04%year on year +0.35%+0.04%+0.35%
- SET$586.0M$586.0Mquarter on quarter +4.2%year on year +6.4%+4.2%+6.4%
- Hips$562.7M$562.7Mquarter on quarter +7.4%year on year +5.0%+7.4%+5.0%
- Technology And Data Bone Cement And Surgical$199.4M$199.4Mquarter on quarter +16%year on year +21%+16%+21%
Medical Devices
The closest names by size in the same industry